Last reviewed · How we verify
NCT06813092: FeDeBoMa
Effects of Resistance Exercise Compared to Whole-body Electromyostimulation in Young Female Dentists.
NA trial testing Whole-Body Electromyostimulation in Osteopenia in 16 participants. Completed in 30 August 2025.
15 July 2025
Quick facts
| Lead sponsor | University of Erlangen-Nürnberg Medical School |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 16 |
| Start date | 15 March 2025 |
| Primary completion | 15 July 2025 |
| Estimated completion | 30 August 2025 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- Whole-Body Electromyostimulation
- Resistance exercise
Conditions studied
- Osteopenia — all drugs for Osteopenia →
- Cardiometabolic Conditions — all drugs for Cardiometabolic Conditions →
Sponsor
University of Erlangen-Nürnberg Medical School
Who can join
Adults 18 to 30, female only, with Osteopenia or Cardiometabolic Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Due to their high workload and unfavorable working position, young female dentists are particularly at risk of cardiometabolic diseases and an early reduction in bone mineral density (BMD). With focus on the latter issue, short bouts of resistance exercise with high strain magnitude and velocity are commonly considered to be a feasible option to prevent bone loss in the early years of young adulthood. In parallel, whole-body electromyostimulation (WB-EMS) a trainings technology able address all main muscle groups simultaneously, however with dedicated exercise intensity might be a time-effective, joint friendly and safe option to maintain BMD in people unable or unmotivated to exercise conventionally. In the present study, we aim to compare the effects of a single session of WB-EMS versus high intensity, high velocity resistance exercise on biomarkers of bone formation (Procollagen type 1 N propeptide, P1NP) and resorption (C-terminal telopeptide of type I collagen, CTX-I). We hypothesize that no clinically relevant different effects on P1NP and CTX-I were determined.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06813092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Whole-Body Electromyostimulation
Trials testing the same drug.
- NCT06584578 — Exercise Nutrition and Body Composition · NA · active not recruiting
- NCT05672264 — Whole-Body Electromyostimulation and Knee Osteoarthritis · Phase 3 · completed
- NCT04495647 — Feasibility of WB-EMS in Frail Older People · NA · completed
Other recruiting trials for Osteopenia
Currently open trials in the same condition.
- NCT07473713 — Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia · Phase 1 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
- NCT07187518 — Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device · NA · recruiting
- NCT07191353 — Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women · Phase 2 · recruiting
Other University of Erlangen-Nürnberg Medical School trials
Trials by the same sponsor.
- NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
- NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
- NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06813092 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06813092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing